Initial Statement of Beneficial Ownership (3)
April 01 2020 - 3:21PM
Edgar (US Regulatory)
FORM 3
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0104
Estimated average burden hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
Olds Donald |
2. Date of Event Requiring Statement (MM/DD/YYYY)
4/1/2020
|
3. Issuer Name and Ticker or Trading Symbol
Acasti Pharma Inc. [ACST]
|
(Last)
(First)
(Middle)
545 PROMENADE DU CENTROPOLIS, SUITE 100 |
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
__X__ Director _____ 10% Owner _____ Officer (give title below) _____ Other (specify below)
|
(Street)
LAVAL, A8 H7T 0A3
(City)
(State)
(Zip)
| 5. If Amendment, Date Original Filed(MM/DD/YYYY)
| 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Beneficially Owned
|
1.Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
Common Shares | 38000 | I | Ofra Aslan (Spouse) (6) |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security (Instr. 4) | 2. Date Exercisable and Expiration Date (MM/DD/YYYY) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) |
Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Share Option (Right to Buy) | (1) | 7/2/2028 | Common Shares | 50000 | $0.77 (5) | D | |
Share Option (Right to Buy) | (2) | 4/15/2029 | Common Shares | 11800 | $1.28 (5) | D | |
Share Option (Right to Buy) | (3) | 4/15/2029 | Common Shares | 40400 | $1.28 (5) | D | |
Share Option (Right to Buy) | (4) | 3/31/2030 | Common Shares | 86000 | $0.53 (5) | D | |
Explanation of Responses: |
(1) | Represents 50,000 common shares underlying 50,000 share options granted on July 2, 2018. These share options vested in 6 equal installments on a quarterly basis starting from July 2, 2018 until January 2, 2020. |
(2) | Represents 11,800 common shares underlying 11,800 share options granted on April 15, 2019. These share options vest in 6 equal installments on a quarterly basis starting from April 15, 2019 until October 15, 2020. |
(3) | Represents 40,400 common shares underlying 40,400 share options granted on April 15, 2019. These share options vest in 6 equal installments on a quarterly basis starting from April 15, 2019 until October 15, 2020. |
(4) | Represents 86,000 common shares underlying 86,000 share options granted on March 31, 2020. These share options vest in 12 equal installments on a monthly basis starting from March 31, 2020 until March 31, 2021. |
(5) | Canadian dollars. |
(6) | 38,000 common shares held by Mr. Olds' wife, Ofra Aslan. Mr. Olds disclaims beneficial ownership of the common shares held by his wife and this report shall not be deemed an admission that Mr. Olds is a beneficial owner of such for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. |
Remarks: Exhibit List - Exhibit 24 - Power of Attorney |
Reporting Owners
|
Reporting Owner Name / Address | Relationships |
Director | 10% Owner | Officer | Other |
Olds Donald 545 PROMENADE DU CENTROPOLIS SUITE 100 LAVAL, A8 H7T 0A3 | X |
|
|
|
Signatures
|
/s/ Kelsey Weiner, Attorney-in-Fact | | 4/1/2020 |
**Signature of Reporting Person | Date |
Acasti Pharma (NASDAQ:ACST)
Historical Stock Chart
From Apr 2024 to May 2024
Acasti Pharma (NASDAQ:ACST)
Historical Stock Chart
From May 2023 to May 2024